对1-3-7消除疟疾战略的影响和有效性证据进行系统审查。

IF 2.4 3区 医学 Q3 INFECTIOUS DISEASES Malaria Journal Pub Date : 2024-12-18 DOI:10.1186/s12936-024-05200-w
Nihal Sogandji, Anna Stevenson, Michael Y Luo, Gao Qi, Richard J Maude
{"title":"对1-3-7消除疟疾战略的影响和有效性证据进行系统审查。","authors":"Nihal Sogandji, Anna Stevenson, Michael Y Luo, Gao Qi, Richard J Maude","doi":"10.1186/s12936-024-05200-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The 1-3-7 approach to eliminate malaria was first implemented in China in 2012. It has since been expanded to multiple countries, but no systematic review has examined the evidence for its use. A systematic review was conducted aiming to evaluate the impact and effectiveness of the strategy and identify key challenges and variations in its implementation across different countries.</p><p><strong>Methods: </strong>PUBMED, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CABS Abstracts, LILACS, Global Health, Medrxiv, Biorxiv were searched for all studies containing 1-3-7 and articles included if they contained information on 1-3-7 impact, effectiveness, challenges and/or adaptations for implementation in different countries.</p><p><strong>Results: </strong>31 studies were included from China (19), Thailand (6), Myanmar (2), Tanzania (1), Cambodia (1), India (1) and Vietnam (1). During 1-3-7 implementation, malaria cases in China decreased by 99.1-99.9%, in Thailand by 66.9% during 2013-19, 65,1% in Cambodia during 2015-17 and 30.3% in India during 2015-16, with some differences in implementation. It was not possible to separate the impact of 1-3-7 from that due to other contemporaneous interventions. Implementing the 1-3-7 policy was largely effective, with reporting within 1 day in 99.8-100% of individuals in China and 36-100% in other countries, investigation within 3 days in 81.5-99.4% in China and 79.4-100% in other countries, and foci investigation within 7 days in 90.1-100% in China and 83.2-100% in other countries. Adaptations to 1-3-7 were described in 5 studies, mostly adjustment of the timing and/or definitions of each component. Key challenges identified included those related to staffing, equipment, process, and patient-provided information.</p><p><strong>Conclusion: </strong>Overall, the 1-3-7 approach was effectively implemented with a concomitant decrease in cases in malaria elimination settings, however, it was not possible to quantify impact as it was not implemented in isolation. Implementing adequate measures for testing, reporting, treatment, and containment is crucial for its success, which is dependent on the availability of resources, infrastructure, staffing, and consistent compliance across regions and throughout the year. However, achieving this nationally and maintaining compliance, especially at borders with malaria-affected countries, poses significant challenges.</p>","PeriodicalId":18317,"journal":{"name":"Malaria Journal","volume":"23 1","pages":"371"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657205/pdf/","citationCount":"0","resultStr":"{\"title\":\"Systematic review of evidence for the impact and effectiveness of the 1-3-7 strategy for malaria elimination.\",\"authors\":\"Nihal Sogandji, Anna Stevenson, Michael Y Luo, Gao Qi, Richard J Maude\",\"doi\":\"10.1186/s12936-024-05200-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The 1-3-7 approach to eliminate malaria was first implemented in China in 2012. It has since been expanded to multiple countries, but no systematic review has examined the evidence for its use. A systematic review was conducted aiming to evaluate the impact and effectiveness of the strategy and identify key challenges and variations in its implementation across different countries.</p><p><strong>Methods: </strong>PUBMED, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CABS Abstracts, LILACS, Global Health, Medrxiv, Biorxiv were searched for all studies containing 1-3-7 and articles included if they contained information on 1-3-7 impact, effectiveness, challenges and/or adaptations for implementation in different countries.</p><p><strong>Results: </strong>31 studies were included from China (19), Thailand (6), Myanmar (2), Tanzania (1), Cambodia (1), India (1) and Vietnam (1). During 1-3-7 implementation, malaria cases in China decreased by 99.1-99.9%, in Thailand by 66.9% during 2013-19, 65,1% in Cambodia during 2015-17 and 30.3% in India during 2015-16, with some differences in implementation. It was not possible to separate the impact of 1-3-7 from that due to other contemporaneous interventions. Implementing the 1-3-7 policy was largely effective, with reporting within 1 day in 99.8-100% of individuals in China and 36-100% in other countries, investigation within 3 days in 81.5-99.4% in China and 79.4-100% in other countries, and foci investigation within 7 days in 90.1-100% in China and 83.2-100% in other countries. Adaptations to 1-3-7 were described in 5 studies, mostly adjustment of the timing and/or definitions of each component. Key challenges identified included those related to staffing, equipment, process, and patient-provided information.</p><p><strong>Conclusion: </strong>Overall, the 1-3-7 approach was effectively implemented with a concomitant decrease in cases in malaria elimination settings, however, it was not possible to quantify impact as it was not implemented in isolation. Implementing adequate measures for testing, reporting, treatment, and containment is crucial for its success, which is dependent on the availability of resources, infrastructure, staffing, and consistent compliance across regions and throughout the year. However, achieving this nationally and maintaining compliance, especially at borders with malaria-affected countries, poses significant challenges.</p>\",\"PeriodicalId\":18317,\"journal\":{\"name\":\"Malaria Journal\",\"volume\":\"23 1\",\"pages\":\"371\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-12-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657205/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Malaria Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12936-024-05200-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaria Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12936-024-05200-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景:中国于2012年首次实施1-3-7消除疟疾方法。此后,它已扩展到多个国家,但尚未对其使用的证据进行系统审查。进行了系统审查,旨在评估该战略的影响和有效性,并确定在不同国家实施该战略的主要挑战和差异。方法:检索PUBMED、Cochrane中央对照试验注册中心(Central)、MEDLINE、EMBASE、CABS Abstracts、LILACS、Global Health、Medrxiv、Biorxiv中包含1-3-3的所有研究,以及包含1-3-3在不同国家实施的影响、有效性、挑战和/或适应性信息的文章。结果:中国(19)、泰国(6)、缅甸(2)、坦桑尼亚(1)、柬埔寨(1)、印度(1)、越南(1)共纳入31项研究。1-3-7实施期间,中国疟疾病例减少99.1-99.9%,泰国2013-19年减少66.9%,柬埔寨2015-17年减少65.1%,印度2015-16年减少30.3%,但实施情况存在一定差异。不可能将1-3-7的影响与其他同期干预措施的影响分开。1-3-7政策实施效果良好,中国1天内报告率为99.8-100%,其他国家为36-100%;中国81.5-99.4%,其他国家为79.4-100%;中国90.1-100%,其他国家83.2-100%,疫源地调查7天内完成。有5项研究描述了对1-3-7的适应,主要是对每个组成部分的时间和/或定义的调整。确定的主要挑战包括与人员配置、设备、流程和患者提供的信息相关的挑战。结论:总体而言,1-3-7方法得到了有效实施,同时在消除疟疾的环境中减少了病例,然而,由于它不是孤立实施的,因此无法量化其影响。实施适当的检测、报告、治疗和遏制措施对其成功至关重要,这取决于资源、基础设施、人员配备的可用性以及各区域和全年的一贯遵守情况。然而,在全国范围内实现这一目标并保持遵守,特别是在受疟疾影响国家的边境地区,构成了重大挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Systematic review of evidence for the impact and effectiveness of the 1-3-7 strategy for malaria elimination.

Background: The 1-3-7 approach to eliminate malaria was first implemented in China in 2012. It has since been expanded to multiple countries, but no systematic review has examined the evidence for its use. A systematic review was conducted aiming to evaluate the impact and effectiveness of the strategy and identify key challenges and variations in its implementation across different countries.

Methods: PUBMED, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CABS Abstracts, LILACS, Global Health, Medrxiv, Biorxiv were searched for all studies containing 1-3-7 and articles included if they contained information on 1-3-7 impact, effectiveness, challenges and/or adaptations for implementation in different countries.

Results: 31 studies were included from China (19), Thailand (6), Myanmar (2), Tanzania (1), Cambodia (1), India (1) and Vietnam (1). During 1-3-7 implementation, malaria cases in China decreased by 99.1-99.9%, in Thailand by 66.9% during 2013-19, 65,1% in Cambodia during 2015-17 and 30.3% in India during 2015-16, with some differences in implementation. It was not possible to separate the impact of 1-3-7 from that due to other contemporaneous interventions. Implementing the 1-3-7 policy was largely effective, with reporting within 1 day in 99.8-100% of individuals in China and 36-100% in other countries, investigation within 3 days in 81.5-99.4% in China and 79.4-100% in other countries, and foci investigation within 7 days in 90.1-100% in China and 83.2-100% in other countries. Adaptations to 1-3-7 were described in 5 studies, mostly adjustment of the timing and/or definitions of each component. Key challenges identified included those related to staffing, equipment, process, and patient-provided information.

Conclusion: Overall, the 1-3-7 approach was effectively implemented with a concomitant decrease in cases in malaria elimination settings, however, it was not possible to quantify impact as it was not implemented in isolation. Implementing adequate measures for testing, reporting, treatment, and containment is crucial for its success, which is dependent on the availability of resources, infrastructure, staffing, and consistent compliance across regions and throughout the year. However, achieving this nationally and maintaining compliance, especially at borders with malaria-affected countries, poses significant challenges.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Malaria Journal
Malaria Journal 医学-寄生虫学
CiteScore
5.10
自引率
23.30%
发文量
334
审稿时长
2-4 weeks
期刊介绍: Malaria Journal is aimed at the scientific community interested in malaria in its broadest sense. It is the only journal that publishes exclusively articles on malaria and, as such, it aims to bring together knowledge from the different specialities involved in this very broad discipline, from the bench to the bedside and to the field.
期刊最新文献
 Increasing the resolution of malaria early warning systems for use by local health actors. Quantifying the potential value of entomological data collection for programmatic decision-making on malaria control in sub-Saharan African settings. Genetic diversity of Plasmodium falciparum reticulocyte binding protein homologue-5, which is a potential malaria vaccine candidate: baseline data from areas of varying malaria endemicity in Mainland Tanzania. Evaluating programmatic reactive focal drug administration impact on malaria incidence in northern Senegal: an interrupted time series analysis. Hospital attendance, malaria prevalence and self-medication with an antimalarial drug before and after the start of COVID-19 pandemic in a sentinel site for malaria surveillance in Gabon.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1